Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.5324
-0.01
(-1.12%)
USD |
OTCM |
Sep 09, 16:00
Reviva Pharmaceuticals Holdings Debt to Equity Ratio : 0.0095 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0095 |
| March 31, 2026 | 0.0133 |
| December 31, 2025 | 0.0471 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | -0.2466 |
| March 31, 2025 | -0.0503 |
| December 31, 2024 | 0.5639 |
| September 30, 2024 | -0.0083 |
| June 30, 2024 | -0.0343 |
| March 31, 2024 | -0.2467 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.0261 |
| June 30, 2023 | 0.1372 |
| March 31, 2023 | 0.1154 |
| December 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| February 29, 2020 | 0.013 |
| November 30, 2019 | 0.00 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Jaguar Health, Inc. | 2.767 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 21.14M |
| Total Liabilities (Quarterly) | 5.933M |
| Shareholders Equity (Quarterly) | 15.21M |
| Current Ratio | 3.563 |
| Net Debt Paydown Yield | 0.19% |